These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 6156328)
1. Coronary vasodilator and cardiac effects of optical isomers of verapamil in the dog. Satoh K; Yanagisawa T; Taira N J Cardiovasc Pharmacol; 1980; 2(3):309-18. PubMed ID: 6156328 [TBL] [Abstract][Full Text] [Related]
2. Optical isomers of verapamil on canine heart. Prevention of ventricular fibrillation induced by coronary artery occlusion, impaired atrioventricular conductance and negative inotropic and chronotropic effects. Kaumann AJ; Serur JR Naunyn Schmiedebergs Arch Pharmacol; 1975; 291(4):347-58. PubMed ID: 1207784 [TBL] [Abstract][Full Text] [Related]
3. Cardioselective effects of gallopamil compared with verapamil in the dog heart. Takahashi K; Tsuchida K; Aihara H Arch Int Pharmacodyn Ther; 1988; 295():157-73. PubMed ID: 3245731 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of optical isomers of cibenzoline, assessed in the canine isolated, blood-perfused papillary muscle and sinoatrial node preparations. Takehana S; Sugiyama A; Hashimoto K J Cardiovasc Pharmacol; 1999 Nov; 34(5):660-5. PubMed ID: 10547081 [TBL] [Abstract][Full Text] [Related]
5. Different antagonism of the positive chronotropic and inotropic responses of the isolated, blood-perfused dog atrium to Bay k 8644 by nicardipine and verapamil. Furukawa Y; Ogiwara Y; Akahane K; Chiba S Eur J Pharmacol; 1988 Nov; 156(2):231-7. PubMed ID: 2467822 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of verapamil enantiomer combinations in conscious dogs. Pagel PS; Hettrick DA; Lowe D; Gowrie PW; Kersten JR; Bosnjak ZJ; Warltier DC Eur J Pharmacol; 1998 May; 348(2-3):213-21. PubMed ID: 9652336 [TBL] [Abstract][Full Text] [Related]
7. Coronary vasodilator and cardiac effects of NKY-722, a novel hydrophilic 1,4-dihydropyridine derivative, in the blood-perfused dog heart. Imagawa J; Satoh K; Taira N Cardiovasc Drugs Ther; 1989 Mar; 3(1):81-90. PubMed ID: 2487526 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological profile of a new coronary vasodilator drug, 2-nicotinamidoethyl nitrate (SG-75). Taira N; Satoh K; Yanagisawa T; Imai Y; Hiwatari M Clin Exp Pharmacol Physiol; 1979; 6(3):301-16. PubMed ID: 157241 [TBL] [Abstract][Full Text] [Related]
9. Contrasting effects of nifedipine and verapamil on myocardium and vascular smooth muscle at two levels of coronary occlusion in the dog. Weintraub WS; Hattori S; Agarwal JB; Bodenheimer MM; Banka VS; Helfant RH Am Heart J; 1983 Dec; 106(6):1347-52. PubMed ID: 6650356 [TBL] [Abstract][Full Text] [Related]
10. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity. Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652 [TBL] [Abstract][Full Text] [Related]
11. The effects of verapamil and nimodipine on bupivacaine-induced cardiotoxicity in rats: an in vivo and in vitro study. Adsan H; Tulunay M; Onaran O Anesth Analg; 1998 Apr; 86(4):818-24. PubMed ID: 9539608 [TBL] [Abstract][Full Text] [Related]
12. Effects on atrioventricular conduction and blood flow of enantiomers of verapamil and of tetrodotoxin injected into the posterior and the anterior septal artery of the atrioventricular node preparation of the dog. Satoh K; Yanagisawa T; Taira N Naunyn Schmiedebergs Arch Pharmacol; 1979 Aug; 308(2):89-98. PubMed ID: 503249 [No Abstract] [Full Text] [Related]
13. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms. Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175 [TBL] [Abstract][Full Text] [Related]
14. The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review. Soward AL; Vanhaleweyk GL; Serruys PW Drugs; 1986 Jul; 32(1):66-101. PubMed ID: 2874975 [TBL] [Abstract][Full Text] [Related]
15. Differences in cardiovascular profile among calcium antagonists. Taira N Am J Cardiol; 1987 Jan; 59(3):24B-29B. PubMed ID: 3544789 [TBL] [Abstract][Full Text] [Related]
16. Coronary vasodilator compared to cardiac effects of PY 108-068, a new dihydropyridine vasodilator, on isolated, blood-perfused dog-heart preparations. Wada Y; Satoh K; Taira N J Cardiovasc Pharmacol; 1984; 6(5):881-7. PubMed ID: 6209495 [TBL] [Abstract][Full Text] [Related]
17. Profile of coronary vasodilator and cardiac actions of bepridil revealed by use of isolated, blood-perfused heart preparations of the dog. Kawada M; Satoh K; Taira N J Cardiovasc Pharmacol; 1983; 5(4):604-12. PubMed ID: 6193358 [TBL] [Abstract][Full Text] [Related]
18. Inotropic versus chronotropic, dromotropic, and coronary vasodilator actions of DPI 201-106, a novel positive inotropic agent, in the dog heart. Takahashi K; Endoh M; Taira N J Cardiovasc Pharmacol; 1987 Apr; 9(4):451-60. PubMed ID: 2438508 [TBL] [Abstract][Full Text] [Related]
19. Relationship of antiarrhythmic to inotropic activity and antiarrhythmic qualities of the optical isomers of verapamil. Raschack M Naunyn Schmiedebergs Arch Pharmacol; 1976 Sep; 294(3):285-91. PubMed ID: 1004639 [TBL] [Abstract][Full Text] [Related]
20. Comparison of cardiovascular effects of pirmenol with those of disopyramide in isolated canine heart preparations cross-circulated with a donor dog. Sugiyama A; Motomura S; Tamura K; Hashimoto K Jpn J Pharmacol; 1990 May; 53(1):97-110. PubMed ID: 2352380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]